Black Rock Inc. Ikena Oncology, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 354,842 shares of IKNA stock, worth $489,681. This represents 0.0% of its overall portfolio holdings.

Number of Shares

354,842

Previous 1,828,752 80.6%

Holding current value

$489,681

Previous $2.6 Million 77.47%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$1.24 - $1.82 $1.83 Million - $2.68 Million	-1,473,910 Reduced 80.6%	354,842 $585,000
Q1 2024 May 10, 2024	SELL	$1.27 - $2.0 $37,343 - $58,808	-29,404 Reduced 1.58%	1,828,752 $2.6 Million
Q4 2023 Feb 13, 2024	BUY	$1.33 - $4.4 $547,908 - $1.81 Million	411,961 Added 28.49%	1,858,156 $3.66 Million
Q3 2023 Nov 13, 2023	BUY	$4.09 - $6.43 $731,504 - $1.15 Million	178,852 Added 14.11%	1,446,195 $6.26 Million
Q2 2023 Aug 11, 2023	BUY	$3.5 - $7.31 $3.36 Million - $7.02 Million	960,109 Added 312.5%	1,267,343 $8.31 Million

Q1 2023 May 12, 2023	BUY	$2.62 - $4.97 $4,763 - $9,035	1,818 Added 0.6%	307,234 $1.06 Million
Q4 2022 Feb 13, 2023	SELL	$2.0 - $3.7 $393,472 - $727,923	-196,736 Reduced 39.18%	305,416 $812,000
Q3 2022 Nov 14, 2022	BUY	$3.46 - $6.0 $741,837 - $1.29 Million	214,404 Added 74.51%	502,152 $1.78 Million
Q2 2022 Aug 12, 2022	SELL	$3.23 - $7.4 $3.89 Million - $8.92 Million	-1,205,413 Reduced 80.73%	287,748 $1.28 Million
Q1 2022 May 12, 2022	BUY	$5.61 - $13.85 $725,283 - $1.79 Million	129,284 Added 9.48%	1,493,161 $9.11 Million
Q4 2021 Feb 10, 2022	BUY	$10.52 - $16.96 $9.26 Million - $14.9 Million	879,946 Added 181.83%	1,363,877 $17.1 Million
Q3 2021 Nov 09, 2021	BUY	$9.82 - $15.23 $335,775 - $520,759	34,193 Added 7.6%	483,931 $6.11 Million
Q2 2021 Aug 11, 2021	BUY	$13.27 - $26.0 $5.97 Million - $11.7 Million	449,738 New	449,738 $6.31 Million

Others Institutions Holding IKNA

# of Institutions

Shares Held

2.57M

Call Options Held

Put Options Held

View Full List

About Ikena Oncology, Inc.

Ticker IKNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,257,500
Market Cap $50M
Description
Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...

More about IKNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account